Fundraising Fox
Saluda Medical
Bloomington, US · Founded 2023 · Delaware corporation · 488 employees on LinkedIn · 6 known investors
Find your way into Saluda Medical
Sign up to see every warm intro you have to Saluda Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Saluda Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs). The company builds neuromodulation therapies for chronic pain management, serving healthcare providers and patients.
Founders & leadership
KC
Kristin CapliceChief Legal OfficerKristin Caplice is an executive officer at Saluda Medical, a developer of spinal cord stimulation systems for chronic pain management. She has held leadership roles in legal departments, corporate compliance, and governance at public companies.
JS
James SchuermannExecutive
GK
Geoffrey KinghornNamed on SEC filing
Board
JM
RF
Robert FaulknerBoard director
GB
Geoffrey BrookeBoard director
DG
Doug GodshallBoard director
RP
Robert PalmisanoBoard director
CL
Catherine LivingstoneBoard director
Investors · 6
Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M
How we know: press coverage · Not right? Tell us
Action Potential Venture Capital Ltd.reportedScotts Valleyvia Juan-Pablo Mas · board
How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us
Fidelity InvestmentsreportedBoston
How we know: press coverage · Not right? Tell us
REDMILEreportedSan Francisco
How we know: funding news · saludamedical.com · Not right? Tell us
T. Rowe PricereportedBaltimore
How we know: funding news · press coverage · Not right? Tell us
Also in the syndicate · 1
Boston Scientific
Reported raises · per SEC filings
Form D private placements$180M disclosed across 2 of 4 rounds · 2019–2025
▶$30MraisedNov 2025 · 26 investors · Other Health CareRule 506(b)
▶$30MraisedNov 2025 · 26 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Greg PlamondonExecutive Officer
- Kristin CapliceExecutive Officer
- Juan-Pablo MasDirector
- Robert FaulknerDirector
- Doug GodshallDirector
- Geoffrey BrookeDirector
- Robert PalmisanoDirector
- Barry ReganExecutive Officer, Director
- Catherine LivingstoneDirector
- Chris BeareDirector
- Andrew CleelandDirector
- Offering amount
- $30M
- Amount sold
- $30M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$150MraisedApr 2023 · 18 investors · Other Health CareRule 506(b)
▶$150MraisedApr 2023 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Doug GodshallDirector
- Robert FaulknerDirector
- Chris BeareDirector
- Robert PalmisanoDirector
- James SchuermannDirector, Executive Officer
- Greg PlamondonExecutive Officer
- Kristin CapliceExecutive Officer
- Juan-Pablo MasDirector
- Catherine LivingstoneDirector
- Andrew CleelandDirector
- Geoffrey BrookeDirector
- Geoffrey KinghornDirector
- Laureen DeBuonoDirector
- Offering amount
- $150M
- Amount sold
- $150M
- Sales commissions
- $6M
- Placement agents
- BofA Securities, Inc.
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
CarepatronCarepatron provides practice management and clinical workflow software for healthcare clinicians. The platform handles scheduling, patient documentation, billing, and payments in a single application, targeting medical practitioners globally.
GenhealthGenHealth provides AI-based revenue cycle management and administrative automation for healthcare providers and DME teams, handling intake, eligibility, claims, prior authorization, denials, and appeals. Its browser agent extracts data from faxes and documents and routes it into EMR and billing systems, targeting independent physician groups and providers.
Companies working in the same space as Saluda Medical.
In the news
Frequently asked questions
- What does Saluda Medical do?
- Saluda Medical develops the Evoke spinal cord stimulation (SCS) system, which records the spinal cord's physiologic response to stimulation using Evoked Compound Action Potentials (ECAPs). The company builds neuromodulation therapies for chronic pain management, serving healthcare providers and patients.
- Who are Saluda Medical's investors?
- Saluda Medical's investors include Wellington Management, Action Potential Venture Capital Ltd., Fidelity Investments, REDMILE, T. Rowe Price.
- How much funding has Saluda Medical raised?
- Saluda Medical has disclosed $180M raised across 2 of its 4 known rounds.
- Where is Saluda Medical headquartered?
- Saluda Medical is headquartered in Bloomington, US.